methionine has been researched along with Bone Neoplasms in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, Y; Bouvet, M; Han, Q; Hoffman, RM; Hozumi, C; Kubota, Y; Masaki, N; Obara, K; Samonte, C; Wu, J; Wu, NF | 1 |
| Aoki, Y; Bouvet, M; Chawla, SP; Han, Q; Hoffman, RM; Kubota, Y; Masaki, N; Nishida, K; Obara, K; Tome, Y | 1 |
| Han, Q; Hoffman, RM | 1 |
| Allis, CD; Andrulis, IL; Bechet, D; Chi, P; De Jay, N; Dickson, BC; Fahiminiyah, S; Garcia, BA; Grynspan, D; Hameed, M; Hoelper, D; Jabado, N; Jain, SU; Jani, KS; Lewis, PW; Lu, C; Lundgren, SM; Majewski, J; Molden, RC; Muir, TW; Murphy, D; Nadaf, J; Papillon-Cavanagh, S; Pawel, BR; Ran, L; Sawyer, SL; Thompson, CB; Turcotte, RE; Venneti, S; Wunder, JS | 1 |
| Jyrkkiö, S; Lapela, M; Lehikoinen, P; Lindholm, P; Minn, H; Någren, K | 1 |
| Goudarzi, B; Ishikawa, H; Kandatsu, S; Kishimoto, R; Komatsu, S; Obata, T; Yoshikawa, K | 1 |
| Huang, L; Kumta, SM; Lau, CP; Leung, PY; Ng, PK; Tsui, SK | 1 |
| Bellmunt, J; Choueiri, TK; Katz, L | 1 |
| NAGAI, T | 1 |
| Kamada, T; Kandatsu, S; Sagou, K; Suhara, T; Suzuki, K; Tamura, K; Tanada, S; Tian, M; Tomemori, T; Tsuji, H; Tsujii, H; Yoshikawa, K; Zhang, H | 1 |
| Dougherty, JP; Gu, J; Parthasarathi, S; Ron, Y; Varela-Echavarría, A | 1 |
| Chen, J; Levine, AJ; Lin, J; Wu, X | 1 |
| Masuno, H; Okuda, H; Okumura, H; Sakayama, K; Shibata, T | 1 |
| Bassa, P; Hicks, K; Inoue, T; Kim, EE; Korkmaz, M; Podoloff, DA; Tansey, W; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Akhurst, T; Cai, S; Gonen, M; Larson, SM; Macapinlac, HA; Nuñez, R; Osman, I; Riedel, E; Scher, HI; Yeung, HW | 1 |
| Berruyer, M; Dechavanne, M; Delmas, PD; Maillard, C; Serre, CM | 1 |
| Ackerman, NB | 1 |
| Jovanovic, D | 1 |
3 trial(s) available for methionine and Bone Neoplasms
| Article | Year |
|---|---|
Oral-recombinant Methioninase in Combination With Rapamycin Eradicates Osteosarcoma of the Breast in a Patient-derived Orthotopic Xenograft Mouse Model.
Topics: Animals; Bone Neoplasms; Carbon-Sulfur Lyases; Disease Models, Animal; Heterografts; Methionine; Mice; Mice, Nude; Osteosarcoma; Recombinant Proteins; Sirolimus; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2022 |
Lowering and Stabilizing PSA Levels in Advanced-prostate Cancer Patients With Oral Methioninase.
Topics: Administration, Oral; Aged, 80 and over; Bone Neoplasms; Carbon-Sulfur Lyases; Disease Progression; Down-Regulation; Enzyme Replacement Therapy; Humans; Male; Methionine; Middle Aged; Pilot Projects; Prostate-Specific Antigen; Prostatic Neoplasms; Recombinant Proteins | 2021 |
[(11)C]methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Biological Transport; Bone Neoplasms; Carbon Radioisotopes; Female; Humans; Male; Methionine; Middle Aged; Multivariate Analysis; Radiotherapy; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Tomography, Emission-Computed | 2004 |
15 other study(ies) available for methionine and Bone Neoplasms
| Article | Year |
|---|---|
The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression of
Topics: Bone Neoplasms; Ethionine; Humans; Methionine; Osteosarcoma; Racemethionine; Recombinant Proteins | 2023 |
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape.
Topics: Animals; Bone Neoplasms; Carcinogenesis; Child, Preschool; Chondroblastoma; Gene Expression Regulation, Neoplastic; Histones; Humans; Lysine; Mesenchymal Stem Cells; Methionine; Methylation; Methyltransferases; Mice; Mutation; Mutation, Missense; Neoplastic Stem Cells; Nucleosomes; Polycomb Repressive Complex 1; Sarcoma | 2016 |
Preliminary study of carbon-11 methionine PET in the evaluation of early response to therapy in advanced breast cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Female; Humans; Male; Methionine; Middle Aged; Positron-Emission Tomography; Soft Tissue Neoplasms; Treatment Outcome | 2009 |
Detection of bone metastases using diffusion weighted magnetic resonance imaging: comparison with (11)C-methionine PET and bone scintigraphy.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Diffusion Magnetic Resonance Imaging; Female; Humans; Male; Methionine; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Pamidronate, farnesyl transferase, and geranylgeranyl transferase-I inhibitors affects cell proliferation, apoptosis, and OPG/RANKL mRNA expression in stromal cells of giant cell tumor of bone.
Topics: Alkyl and Aryl Transferases; Apoptosis; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Caspases; Cell Division; Cell Survival; Diphosphonates; Drug Synergism; Enzyme Inhibitors; Farnesyltranstransferase; Gene Expression; Giant Cell Tumor of Bone; Humans; Methionine; Osteoprotegerin; Pamidronate; Prenylation; RANK Ligand; RNA, Messenger; S Phase; Tumor Cells, Cultured | 2011 |
¹¹C-methionine positron-emission tomography and computed tomography (PET-CT) in evaluating metastatic transitional cell carcinoma response to sunitinib therapy.
Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Bone Neoplasms; Carbon Radioisotopes; Carcinoma, Transitional Cell; Humans; Indoles; Methionine; Positron-Emission Tomography; Pyrroles; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
[SYMPOSIUM ON NEW DIAGNOSTIC PROCEDURES IN INTERNAL MEDICINE. CLINICAL APPLICATIONS OF IN VIVO COUNTING].
Topics: Bone Neoplasms; Carotid Arteries; Cobalt Isotopes; Edetic Acid; Erythrocytes; Heart; Humans; Internal Medicine; Iodine Isotopes; Iron Isotopes; Liver; Metabolic Diseases; Methionine; Pancreas; Radioisotopes; Radionuclide Imaging; Selenium; Strontium Isotopes | 1963 |
Mutations of conserved cysteine residues in the CWLC motif of the oncoretrovirus SU protein affect maturation and translocation.
Topics: Amino Acid Sequence; Animals; Bone Neoplasms; Cell Line; Conserved Sequence; Cysteine; Dogs; Gene Expression; Genes, env; Glycosylation; Kinetics; Methionine; Molecular Sequence Data; Mutagenesis, Site-Directed; Osteosarcoma; Protein Biosynthesis; Protein Folding; Retroviridae; Transfection; Tumor Cells, Cultured; Viral Envelope Proteins; Virion | 1995 |
mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein.
Topics: 3T3 Cells; Animals; Apoptosis; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line; G1 Phase; Gene Expression; Humans; Lung Neoplasms; Methionine; Mice; Mutagenesis, Site-Directed; Nuclear Proteins; Osteosarcoma; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Recombinant Proteins; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1996 |
Recombinant human tumour necrosis factor-alpha suppresses synthesis, activity and secretion of lipoprotein lipase in cultures of a human osteosarcoma cell line.
Topics: Bone Neoplasms; Carbon Dioxide; Carbon Radioisotopes; Cell Line; Diglycerides; Fatty Acids, Nonesterified; Humans; Kinetics; Lipids; Lipoprotein Lipase; Methionine; Osteosarcoma; Phospholipids; Recombinant Proteins; Sulfur Radioisotopes; Triglycerides; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1996 |
Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts.
Topics: Bone and Bones; Bone Neoplasms; Cell Line; Glycoproteins; Humans; Immunoblotting; Immunohistochemistry; Methionine; Osteoblasts; Osteocalcin; Osteosarcoma; Precipitin Tests; Protein S; Sulfur Radioisotopes; Tumor Cells, Cultured | 1992 |
Clinical and experimental uses of radioisotopes in the diagnosis of cancer.
Topics: Bone Neoplasms; Brain Neoplasms; Calcium Isotopes; Cesium Isotopes; DNA; Eye Neoplasms; Fluorine; Gallium; Humans; Iodine Radioisotopes; Liver Neoplasms; Methionine; Neoplasms; Phosphorus Isotopes; Radionuclide Imaging; Rubidium; Selenium; Strontium Isotopes; Thyroid Neoplasms | 1968 |
75Se-selenomethionine uptake by malignant tumours.
Topics: Blood Specimen Collection; Bone Neoplasms; Carcinoma; Hodgkin Disease; Humans; Injections, Intravenous; Lung Neoplasms; Lymphoma, Non-Hodgkin; Methionine; Myosarcoma; Neoplasms; Radioisotopes; Radiometry; Radionuclide Imaging; Rhabdomyosarcoma; Selenium; Temporal Bone | 1968 |